Regulation of rat pial arteriolar smooth muscle relaxation in vivo through multidrug resistance protein 5-mediated cGMP efflux

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  Xu, Hao Liang ^a   Gavrilyuk, Vitaliy ^a   Wolde, Hailemariam M ^a   Baughman, Verna L ^a   Pelligrino, Dale A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antisense oligodeoxynucleotide; Guanosine 3 ,5 cyclic monophosphate; Nitric oxide

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; CYCLIC GMP; ENZYME ACTIVATOR; MULTIDRUG RESISTANCE PROTEIN 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DESENSITIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARACHNOID; ARTERIOLES; CARBON DIOXIDE; CYCLIC GMP; ENZYME INHIBITORS; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; OLIGONUCLEOTIDES, ANTISENSE; PIA MATER; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VASODILATION;

EID: 1942501575     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01105.2003     Document Type: Article

References (32)

1. Armstead WM. Relationship among NO, the K-ATP channel, and opioids in hypoxic pial artery dilation. Am J Physiol Heart Circ Physiol 275: H988-H994, 1998.
2. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75: 725-748, 1995.
3. Boadu E, Vaskinn S, Sundkvist E, Jaeger R, and Sager G. Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [(3)H]3′,5′-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles. Biochem Pharmacol 62: 425-429, 2001.
4. Borst P and Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71: 537-592, 2002.
5. Dagle JM and Weeks DL. Oligonucleotide-based strategies to reduce gene expression. Differentiation 69: 75-82, 2001.
6. Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, and Feinstein DL. Peroxisome proliferator-activated receptor-γ thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem 278: 5828-5836, 2003.
7. Ferrero R, Rodriguez Pascual F, Mirasportugal MT, and Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J Neurochem 75: 2029-2039, 2000.
8. Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, and Feinstein DL. Norepinephrine increases IKBa expression in astrocytes. J Biol Chem 277: 29662-29668, 2002.
9. Golden T, Dean NM, and Honkanen RE. Use of antisense oligonucleotides: advantages, controls, and cardiovascular tissue. Microcirculation 9: 51-64, 2002.
10. Hirrlinger J, Konig J, and Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 82: 716-719, 2002.
11. Irikura K, Huang PL, Ma JY, Lee WS, Dalkara T, Fishman MC, Dawson TM, Snyder SH, and Moskowitz MA. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci USA 92: 6823-6827, 1995.
12. Jedlitschky G, Burchell B, and Keppler D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 275: 30069-30074, 2000.
13. -ΔΔCt method. Methods 25: 402-408, 2001.
14. Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, and Koesling D. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. J Cell Biol 160: 719-727, 2003.
15. Nies AT, Spring H, Thon WF, Keppler D, and Jedlitschky G. Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. J Urol 167: 2271-2275, 2002.
16. Pelligrino DA and Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 56: 1-18, 1998.
17. Schmidt K, Schrammel A, Koesling D, and Mayer B. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells. Mol Pharmacol 59: 220-224, 2001.
18. Sellak H, Yang X, Cao X, Cornwell T, Soff GA, and Lincoln T. Sp1 transcription factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-1 alpha expression in vascular smooth muscle cells. Circ Res 90: 405-412, 2002.
19. Sobey CG and Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 277: H1718-H1724, 1999.
20. Soff GA, Cornwell TL, Cundiff DL, Gately S, and Lincoln TM. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100: 2580-2587, 1997.
21. Sporbert A, Mertsch K, Smolenski A, Haseloff RF, Schonfelder G, Paul M, Ruth P, Walter U, and Blasig IE. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide and cGMP mediated signal transduction in brain capillary endothelial cells and astrocytes. Mol Brain Res 67: 258-266, 1999.
22. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Pleiss U, Schroder H, Schroeder W, Stahl E, Steinke W, Straub A, and Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature 410: 212-215, 2001.
23. Wang Q, Bryowsky J, Minshall RD, and Pelligrino DA. Possible obligatory functions of cyclic nucleotides in hypercapnia-induced cerebral vasodilation in adult rats. Am J Physiol Heart Circ Physiol 276: H480-H487, 1999.
24. G-nitro-L-arginine and indomethacin on the hypercapnic cerebral blood flow increase in rats. Brain Res 641: 257-264, 1994.
25. Wang Q, Theard A, Pelligrino DA, Baughman VL, Hoffman WE, Albrecht RF, Cwik M, Paulson OB, and Lassen NA. Nitric oxide as an endogenous anticonvulsant but not a mediator of the cerebral hyperemia accompanying bicuculline treatment in rats. Brain Res 658: 192-198, 1994.
26. Wielinga PR, Van DH, I, Reid G, Beijnen JH, Wijnholds J, and Borst P. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278: 17664-17671, 2003.
27. Wykes V, Bellamy TC, and Garthwaite J. Kinetics of nitric oxide-cyclic GMP signalling in CNS cells and its possible regulation by cyclic GMP. J Neurochem 83: 37-47, 2002.
28. Xu HL, Feinstein DL, Santizo RA, Koenig HM, and Pelligrino DA. Agonist-specific differences in mechanisms mediating eNOS-dependent pial arteriolar dilation in rats. Am J Physiol Heart Circ Physiol 282: H237-H243, 2002.
29. Xu HL, Galea E, Santizo RA, Baughman VL, and Pelligrino DA. The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo. J Cereb Blood Flow Metab 21: 907-913, 2001.
30. Xu HL, Santizo RA, Baughman VL, and Pelligrino DA. ADP-induced pial arteriolar dilation in ovariectomized rats involves gap junctional communication. Am J Physiol Heart Circ Physiol 283: H1082-H1091, 2002.
31. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, and Yokoyama M. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102, 2000.
32. Zhang Y, Han H, Elmquist WF, and Miller DW. Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 876: 148-153, 2000.